Harvey M. Golomb to Topoisomerase I Inhibitors
This is a "connection" page, showing publications Harvey M. Golomb has written about Topoisomerase I Inhibitors.
Connection Strength
0.012
-
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33.
Score: 0.012
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.